Bryce Linkous

PGY-2 at Case Western Reserve University/University Hospitals | neurology & learning & art |

[Bryce Linkous @neuralinkous]

Many ideas are older than we think. https://t.co/Km9aC4wtWd

[Bryce Linkous @neuralinkous]

What medical fields are in their “brand age”? https://t.co/Ikr6G5ASqH

[Bryce Linkous @neuralinkous]

Really cool: “mRNA-based COVID vaccines generate improved responses to immunotherapy” https://t.co/vTMj8eb8Li

[Nikhil Krishnan @nikillinit]

It's pretty clear that healthcare costs are going to go up in the near term with the introduction of AI

Three reasons for this. The first is simple - payers are being much more heavily scrutinized for their use of AI in preventing $ going out, while hospitals/companies using AI to bill more have a ton of leeway.

The second is that the current billing rails incentivizes AI use cases that are "add-on" billing line items. Consider the AI second reads of mammograms which are an up charge, the AI diabetic retinopathy screens that bill more than their human counterparts, etc. which are all effectively upcharges.

The third is that more people now have access to a self-diagnosing and triage tool, but also still need to go to the health system to resolve their issue if they need confirmatory labs, screening a prescription, etc. That's going to create more utilization inherently, though how much more than just using Google is TBD.

--

Every time technology has been introduced into healthcare it's caused costs to be inflationary. My hope is that AI becomes a tool that makes costs deflationary, but there needs to be a clearer path for that to happen.

[Bryce Linkous @neuralinkous]

https://t.co/bnzBdiz1IT

[Bryce Linkous @neuralinkous]

Can the approval process for human therapeutics be amended to be closer to the process for animals? After all, the FDA regulates both.

[Bryce Linkous @neuralinkous]

Neurology in Clinical Practice can be read cover-to-cover after all! https://t.co/to4xdTnyM5

[Bryce Linkous @neuralinkous]

An observation that is not widely known but important to policy-making and resource allocation. https://t.co/9v9WUiIXUz

[Bryce Linkous @neuralinkous]

A look inside how Cigna reviews patient cases. https://t.co/MCelEFWV6x

[Bryce Linkous @neuralinkous]

Medical debt is complicated. https://t.co/plJNPkEvOW

[Bryce Linkous @neuralinkous]

"...less likely to cause bleeding" would be a better phrase than "...without causing bleeding". https://t.co/MSVh6Jhsxq

[Bryce Linkous @neuralinkous]

March's cartoon has landed. https://t.co/SvIoDZMZhc

[Bryce Linkous @neuralinkous]

Translational research is still only in the blastocyst phase, but there are exciting ideas here. https://t.co/3WFclLuYaQ

[Bryce Linkous @neuralinkous]

@SholaOlaoluwaa Congratulations, Shola!

[Bryce Linkous @neuralinkous]

I imagine cognitive impairment, as a core symptom of schizophrenia, prevents the use of this coping mechanism for many patients.
https://t.co/SQ9edrqzbg

[Bryce Linkous @neuralinkous]

I have now updated my use of "no evidence" when speaking with patients.
https://t.co/oCcj8IAmIv

[Bryce Linkous @neuralinkous]

What other lab practices in place today are tomorrow’s mouth pipette? https://t.co/GMpwWkfgC4

[Bryce Linkous @neuralinkous]

Exciting news for the future of academic medicine in Dayton. https://t.co/g3oyHMoY4L

[Bryce Linkous @neuralinkous]

FDA regulation of lab tests: high costs and decreased incentives to innovate without commensurate benefits. https://t.co/VRpw4fFKf7

[Bryce Linkous @neuralinkous]

The opportunities abound, but I imagine “total mission value” will hold different meanings between patients, doctors, and the system as a whole.
https://t.co/S04vaMyr5j